15-28 Mar 2022 Central Clinical School recent publications

Paul Myles argues that there needs to be a stronger focus on
patient-reported outcomes: Future of Clinical Trials article.

Recent publications featuring research as notified by PubMed during 15-28 March 2022 from Central Clinical School affiliated researchers in the following departments. The below is not a comprehensive list.

The most recent validated publications for the school and departments can be seen on their publications pages, linked to from the headings below. Otherwise, read down the entry for recent notifications.

Monash University/UCL Perioperative Medicine Short Course 2022

Monash University and University College London (UCL) Perioperative Medicine Short Course 2022 (July and October)

Perioperative medicine is an emerging field of medicine that has developed in response to the increasing age and complexity of patients and in the number of surgical procedures being performed. The course has been developed as a collaboration between perioperative medicine experts at both Monash University and University College London and aims to provide a comprehensive overview of topics considered important in the field.

Registration for the Monash University/UCL Perioperative Medicine Short Course 2022 has now opened. See more below or download the flier.

Congratulations to Dr Leo Chen on his PhD completion

Congratulations to Dr Leonard Chen on his PhD completion, on 16 March 2022. Leo was supervised by Professor Paul Fitzgerald and Professor Kate Hoy in CCS's Department of Psychiatry. His thesis is titled, "Improving Efficacy and Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Major Depression and Comorbid Anxiety."

Leo's thesis examined repetitive transcranial magnetic stimulation’s (rTMS) parameters and scheduling to optimise its efficacy and efficiency in treating depression. Depression is a common mental illness that often presents with anxiety symptoms, both of which can be difficult to treat.

Thank you to Alex Dimitropoulos for GEDI work!

Ms Alex Dimitropoulos

Ms Alex Dimitropoulos is a PhD student in the Department of Diabetes, and has been the student representative on the Gender, Equity, Diversity and Inclusion (GEDI) committee of the Central Clinical School. The GEDI chair, Dr Jessica Borger, writes:

"I wanted to acknowledge what an outstanding job Alex performed in her role within the committee. I was also very impressed by her confidence to participate actively in all of our meetings, and present and discuss the issues of students at the CCS so eloquently.

Eye movements may be key to chronic fatigue syndrome diagnosis

Oculomotor testing in the lab

A Monash Central Clinical School scientist has been awarded $180,000 over three years to develop a way to help diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Associate Professor Joanne Fielding, from the Department of Neuroscience, is being funded  by the Judith Jane Mason & Harold Stannet Williams Memorial Foundation (the Mason Foundation) through Equity Trustees to conduct a project identifying objective behavioural markers for this debilitating disorder. Associate Professor Fielding is working with Dr Scott Kolbe and Dr Meaghan Clough, both from the Department, and co-investigator Dr Chris Armstrong from the University of Melbourne on the project.

Ending HIV transmission by Optimizing Pre-exposure prophylaxis in East Asia (HOPE) launch

Aim and methods of the HOPE network

Associate Professor Jason Ong was recently awarded $667,191 by the National Health and Medical Research Council for an NHMRC e-ASIA 2021 Joint Research Program, “Ending HIV transmission by Optimizing Pre-exposure prophylaxis in East Asia (HOPE)”.

The research program was launched this week. A/Prof Ong, a senior research fellow in the Melbourne Sexual Health Centre, said that HIV is a very significant health issue in the Asia-Pacific region.

Participants sought: People with COPD for in-home nasal high flow air therapy

Participants with COPD sought for 8 day in-home study

EAGLE is a phase II trial to assess feasibility of using nasal high flow for breathlessness in participants with chronic obstructive pulmonary disease (COPD) who do not qualify for domiciliary long-term oxygen therapy.

We are seeking participants for our 8-day trial of in-home nasal high flow air therapy for COPD patients who experience breathlessness. The study aims to determine the effects of in-home nasal high flow air therapy on breathlessness, quality of life, and other symptom management. 

Contact Dr Amy Pascoe:

• email amy.pascoe@monash.edu 
• phone +61 3 9903 8930